close 74% rachunków inwestorów detalicznych odnotowuje straty w wyniku handlu kontraktami CFD u niniejszego dostawcy. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 74% rachunków inwestorów detalicznych odnotowuje straty w wyniku handlu kontraktami CFD u niniejszego dostawcy. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Pulpit

LLY

920.2

+0.28%↑

JNJ

235.65

-0.72%↓

ABBV

206.42

-0.47%↓

NVS

146.45

-1.15%↓

AZN

185.48

-1.36%↓

LLY

920.2

+0.28%↑

JNJ

235.65

-0.72%↓

ABBV

206.42

-0.47%↓

NVS

146.45

-1.15%↓

AZN

185.48

-1.36%↓

LLY

920.2

+0.28%↑

JNJ

235.65

-0.72%↓

ABBV

206.42

-0.47%↓

NVS

146.45

-1.15%↓

AZN

185.48

-1.36%↓

LLY

920.2

+0.28%↑

JNJ

235.65

-0.72%↓

ABBV

206.42

-0.47%↓

NVS

146.45

-1.15%↓

AZN

185.48

-1.36%↓

LLY

920.2

+0.28%↑

JNJ

235.65

-0.72%↓

ABBV

206.42

-0.47%↓

NVS

146.45

-1.15%↓

AZN

185.48

-1.36%↓

Strona główna・Stock List・Karyopharm Therapeutics Inc
Search

Karyopharm Therapeutics Inc

Open

SectorHealthcare

8.19 -4.21

Strong Buy

Price update 20 mar 2026, 15:25 UTC

BuySell

Overview

Share price change

24h

Current

Min

7.49

Max

8.49

Key metrics

By Trading Economics

Income

-69M

-102M

Sales

-10M

34M

EPS

-5.69

Profit margin

-299.886

Employees

228

EBITDA

4.7M

-18M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+132.14% upside

Market Stats

By TradingEconomics

Market Cap

-267K

157M

Previous open

12.4

Previous close

8.19

News Sentiment

By Acuity

29%

71%

63 / 350 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

5.9501 / 7.66 Support & Resistance

Karyopharm Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

19 mar 2026, 18:34 UTC

Earnings

Canada to Allow Smaller Companies to Ax Quarterly Earnings Reports in Pilot

DJ

Read

19 mar 2026, 17:43 UTC

Major Market Movers

Ecolab Dips on Report of Deal for CoolIT Systems With KKR

DJ

Read

19 mar 2026, 23:47 UTC

Earnings

COSCO SHIPPING Holdings: Geopolitical Tensions Will Continue Driving Regional Fragmentation >1919.HK

DJ

Read

19 mar 2026, 23:47 UTC

Earnings

COSCO SHIPPING Holdings: Container Shipping Market Saw Fluctuating, Declining Freight Rates >1919.HK

DJ

Read

19 mar 2026, 23:47 UTC

Earnings

COSCO SHIPPING Holdings 2025 Rev CNY219.50B Vs. CNY233.86B >1919.HK

DJ

Read

19 mar 2026, 23:47 UTC

Earnings

COSCO SHIPPING Holdings 2025 Net CNY30.86B Vs. Net CNY49.17B >1919.HK

DJ

Read

19 mar 2026, 23:39 UTC

Earnings

Li Ning 2025 Net CNY2.94B Vs. Net CNY3.01B >2331.HK

DJ

Read

19 mar 2026, 23:39 UTC

Earnings

Li Ning: Will Continue Targeting Consumer Needs, Strengthening User Engagement >2331.HK

DJ

Read

19 mar 2026, 23:39 UTC

Earnings

Li Ning: Outdoor Category Continued Growing >2331.HK

DJ

Read

19 mar 2026, 23:38 UTC

Earnings

Li Ning 2025 Rev CNY29.60B Vs. CNY28.68B >2331.HK

DJ

Read

19 mar 2026, 23:33 UTC

Market Talk

Gold Edges Lower on Inflation Concerns, Dimmed Fed Rate-Cut Hopes -- Market Talk

DJ

Read

19 mar 2026, 22:42 UTC

Acquisitions, Mergers, Takeovers

Unilever in Talks to Separate Food Business and Combine It With McCormick -- WSJ

DJ

Read

19 mar 2026, 22:42 UTC

Acquisitions, Mergers, Takeovers

McCormick Has a Market Value of Around $14.8B -- WSJ

DJ

Read

19 mar 2026, 22:42 UTC

Acquisitions, Mergers, Takeovers

Unilever in Talks to Combine Food Business With McCormick, Sources Say -- WSJ

DJ

Read

19 mar 2026, 22:42 UTC

Acquisitions, Mergers, Takeovers

All-Stock Unilever-McCormick Deal Could Come Together Within Weeks, Sources Say -- WSJ

DJ

Read

19 mar 2026, 22:23 UTC

Market Talk

FedEx Says It Can Raise Prices to Offset Higher Fuel Costs -- Market Talk

DJ

Read

19 mar 2026, 22:09 UTC

Market Talk
Major News Events

Australian Transport Stocks to Trade at Discount On Fuel Risks -- Market Talk

DJ

Read

19 mar 2026, 22:06 UTC

Market Talk

Sigma Healthcare's New Bull Expects Profit Margins to Widen -- Market Talk

DJ

Read

19 mar 2026, 22:04 UTC

Earnings
Acquisitions, Mergers, Takeovers

FedEx CFO: MD-11 Grounding Led to $120M Headwind to Adjusted Operating Income in 3Q

DJ

Read

19 mar 2026, 22:03 UTC

Market Talk
Major News Events

Global Energy Roundup: Market Talk

DJ

Read

19 mar 2026, 22:03 UTC

Market Talk
Major News Events

Fuel Prices, Scarcity Could Leave Mark on Australia's Gold Miners -- Market Talk

DJ

Read

19 mar 2026, 21:51 UTC

Earnings
Acquisitions, Mergers, Takeovers

FedEx CEO: InPost Deal Expected to Be Accretive to Earnings in Year One After Close

DJ

Read

19 mar 2026, 20:57 UTC

Major News Events

Middle East Attacks, Inflation Fears Weigh on Stocks -- WSJ

DJ

Read

19 mar 2026, 20:50 UTC

Market Talk
Major News Events

Basic Materials Roundup: Market Talk

DJ

Read

19 mar 2026, 20:19 UTC

Major News Events

Brent Crude Retreats After Touching $119 -- WSJ

DJ

Read

19 mar 2026, 19:49 UTC

Market Talk

Brent Crude Seen Potentially Rising to Top Its 2008 High -- Market Talk

DJ

Read

19 mar 2026, 19:26 UTC

Major News Events

U.S. Consumers Face 'Global Oil Shock.' The Iran War Is Retail's Latest Challenge. -- Barrons.com

DJ

Read

19 mar 2026, 19:10 UTC

Market Talk
Major News Events

Natural Gas Rises in Volatile Trading -- Market Talk

DJ

Read

19 mar 2026, 19:06 UTC

Major News Events

Brent Crude Prices Are Surging. Why Europe Is Facing an Energy Shock and the U.S. Isn't. -- Barrons.com

DJ

Read

19 mar 2026, 18:08 UTC

Market Talk
Major News Events

Silver Extends Slide to Seven Straight Sessions -- Market Talk

DJ

Read

Peer Comparison

Price change

Karyopharm Therapeutics Inc Forecast

Price Target

By TipRanks

132.14% upside

12 Months Forecast

Average 19.5 USD  132.14%

High 28 USD

Low 12 USD

Based on 5 Wall Street analysts offering 12 month price targets forKaryopharm Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

5 ratings

5

Buy

0

Hold

0

Sell

Based on 5 analysts giving stock ratings to Karyopharm Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

5.9501 / 7.66Support & Resistance

Short Term

Bullish Evidence

Recent bullish events outweigh bearish events.

Intermediate Term

Strong Bearish Evidence

All events are bearish.

Long Term

No Evidence

There are no events.

Sentiment

By Acuity

63 / 350 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

LLY

Eli Lilly and Co.

920.2

↑ +0.28%

JNJ

Johnson and Johnson

235.65

↓-0.72%

ABBV

AbbVie Inc

206.42

↓-0.47%

NVS

Novartis AG

146.45

↓-1.15%

AZN

AstraZeneca PLC

185.48

↓-1.36%
help-icon Live chat